1. Ikotun O, Clark B, Sunderland J. A snapshot of United States PET cyclotron and radiopharmaceutical production operations and locations. J Nucl Med 2012;53(Suppl 1):1085.
2. FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82, Jan 12, 2012. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm287413.htm .
3. FDA Drug Safety Communication: Planned return of CardioGen-82 to market with new Boxed Warning, Feb 15, 2012. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm291758.htm .
4. Klein R, Adler A, Beanlands RS, deKemp RA. Precision controlled elution of a 82Sr/82Rb generator for cardiac perfusion imaging with positron emission tomography. Phys Med Biol 2007;52:659-73.
5. Klein R, Renaud JM, Ziadi MC, Thorn SL, Adler A, Beanlands RS. Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using Rubdium-82 PET and a highly automated analysis program. J Nucl Cardiol 2010;17:600-16.